BRIEF published on 08/26/2026 at 15:07, 15 days 19 hours ago The Vanguard Group Reports Holding in SEGRO plc Takeover Code Vanguard Group Financial Disclosure SEGRO PLC Stock Interests
BRIEF published on 08/26/2026 at 15:06, 15 days 19 hours ago The Vanguard Group Discloses Stake in LondonMetric Property Securities Disclosure Vanguard Group Stake LondonMetric Property
PRESS RELEASE published on 08/26/2026 at 15:06, 15 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.00% interest in Beazley plc with 30,088,567 securities. Dealings include purchases of 5p ordinary shares Disclosure Vanguard Group Purchase Beazley Plc 5.00% Interest
PRESS RELEASE published on 08/26/2026 at 15:05, 15 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses a 5.46% stake in Rotork plc as of 25 August 2026 The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Rotork Plc 5.46%
PRESS RELEASE published on 08/26/2026 at 15:05, 15 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.72% interest in Schroders plc. Details of securities and transactions provided Securities Transactions The Vanguard Group, Inc. Schroders Plc Interest Disclosure
PRESS RELEASE published on 08/26/2026 at 15:04, 15 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% stake in Spire Healthcare Group plc through Form 8.3. Purchase of 1p ordinary shares made at 2.37 GBP per unit Form 8.3 The Vanguard Group Share Purchase Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 08/26/2026 at 15:02, 15 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.67% interest in SEGRO plc with 76,760,277 securities owned. Purchases made at 9.67-9.69 GBP per unit on 25 August 2026 The Vanguard Group Securities Ownership Stock Purchases Interest Disclosure SEGRO PLC
PRESS RELEASE published on 08/26/2026 at 15:01, 15 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. files Form 8.3 for LondonMetric Property plc and Schroder Real Estate Investment Trust. Discloses 5.32% and 0.92% interests in each LondonMetric Property Plc Form 8.3 Disclosure The Vanguard Group Schroder Real Estate Investment Trust
BRIEF published on 08/25/2026 at 15:48, 16 days 18 hours ago Vanguard Group Discloses Position in Prologis, Inc. Financial Transactions Takeover Code Securities Disclosure Vanguard Group Prologis, Inc.
BRIEF published on 08/25/2026 at 15:47, 16 days 18 hours ago The Vanguard Group Discloses Position in DNO Iraq AS Form 8.3 Takeover Code Securities Disclosure Vanguard Group DNO Iraq AS
Published on 09/11/2026 at 04:00, 6 hours 21 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 56 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 1 minute ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 21 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 6 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 1 minute ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 16 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 21 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 21 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 14 hours 51 minutes ago Availability of the 2026 Interim Financial Report
